Sensex

Nifty

USDINR

GBPINR

EURINR

Tuesday, 24 February 2026 01:41 PM	Asian-Paints2404.85	Hind-Unilever2366.65	ITC323.70	Trent3951.00	Larsen-and-Toubro4233.00	M-and-M3405.10	Reliance-Industries1420.65	Tata-Steel207.85	Titan-Company4263.80	SBI1223.90	Bharat-Electron431.10	Kotak-Mah-Bank427.90	Infosys1274.20	Bajaj-Finance1018.40	Sun-PharmaInds1737.20	HDFC-Bank913.40	TCS2577.50	ICICI-Bank1386.10	Power-Grid-Corpn302.05	Maruti-Suzuki14939.00	Axis-Bank1385.90	HCL-Technologies1324.50	NTPC375.20	Bharti-Airtel1934.50	Tech-Mahindra1345.70	Adani-Ports1543.55	UltraTech-Cem12960.00	Bajaj-Finserv2038.00	Interglobe-Aviat4840.10	Eternal252.70
15 mins delay SENSEX 82,041.72 [-1,252.94]	-23.90 -0.98%	21.80 0.93%	-1.65 -0.51%	-102.40 -2.53%	-184.15 -4.17%	-39.90 -1.16%	-7.25 -0.51%	-0.20 -0.10%	-8.55 -0.20%	-3.90 -0.32%	-8.60 -1.96%	-2.80 -0.65%	-54.25 -4.08%	-12.65 -1.23%	5.00 0.29%	-10.45 -1.13%	-98.35 -3.68%	-13.00 -0.93%	-1.30 -0.43%	-128.70 -0.85%	-0.65 -0.05%	-101.85 -7.14%	-0.25 -0.07%	-62.65 -3.14%	-96.05 -6.66%	-13.00 -0.84%	-14.50 -0.11%	-13.05 -0.64%	-21.15 -0.44%	-15.40 -5.74%

Corporate News

Latest News about business and investments.

SteinCares inks strategic licensing agreement with Shilpa Biologicals

24-Feb-26 11:15Hrs IST

SteinCares, a leading specialty healthcare company in Latin America, and Shilpa Biologicals, a fully integrated biopharmaceutical company and subsidiary of Shilpa Medicare, announce a strategic licensing agreement to commercialize a biosimilar across Latin America.

Under the agreement, SteinCares will hold exclusive rights to register, commercialize, and distribute the biosimilar across the region while Shilpa Biologicals will complete product development and provide long-term commercial manufacturing from its facility in Dharwad, India. The partnership brings together Shilpa Biologicals' expertise in biologics development and high quality commercial manufacturing with SteinCares' integrated regional platform, combining regulatory capabilities, market access, and deep understanding of Latin American healthcare systems.

Powered by Capital Market - Live News

Attention Investor :

"Prevent unauthorised transactions in your account ; Update your mobile numbers/email IDs with Us. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day” - Issued in the interest of Investors"

"KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."

"No need to issue cheques by investors while subscribing to Equity IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

A Muthoot M George Enterprise